Bharat Biotech’s ‘COVAXIN’ gets approval for phase 3 trials in India
Team Udayavani, Oct 23, 2020, 9:26 AM IST
Covaxin, the coronavirus vaccine being developed by Bharat Biotech and ICMR, has received the approval by the Drugs Controller General of India (DCGI) to conduct the third phase of clinical trials.
The expert panel’s approval came after assessing data from Phases 1 and 2 along with animal trials. However, the committee suggested “minor amendments” in the protocol.
The study would cover 28,500 participants aged 18 years and above across 10 states. The Serum Institute of India began phase 3 clinical trial of Oxford vaccine last month.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Actress Kasthuri released from jail, says ‘I thank those who made me raging storm’
Kerala HC quashes FIR against Goa Guv over remarks on Sabarimala women entry
Smriti Irani embarks on four-nation tour to promote book on PM Modi
Karnataka Milk Federation enters Delhi-NCR, offers competitive pricing on Nandini products
Rahul, Congress tried since 2002 to target Modi’s image, PM’s credibility remains high: BJP
MUST WATCH
Latest Additions
Siddaramaiah says confident of winning all three bypolls in Karnataka
Hop on! IT Minister Priyank Kharge checks out Uber Shuttle at Bengaluru Tech Summit
Actress Kasthuri released from jail, says ‘I thank those who made me raging storm’
Kidnapped for ransom in 1998, 26/11 survivor Gautam Adani faces biggest trial
AIMPLB to hold its annual general sessions in Bengaluru from November 23
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.